Abstract:Macrophages are an innate immune cell that play a critical role in host defense and maintaining tissue homeostasis, however their infiltration into tumors has been associated with disease progression and resistance to therapy. Tumor associated macrophages (TAMs) represent a significant proportion of solid tumors, including breast cancer. TAMs play a major role in tumorigenesis as they can enhance tumor cell growth, angiogenesis and metastasis. In addition, TAMs can inhibit anti-tumor responses of T cells. Our recent work has shown that removal or conversion of TAMs to an anti-tumor phenotype enhances chemo- and immuno-therapy establishing TAMs as targets for anti-cancer therapy. We recently revealed that a Class II HDAC inhibitor can polarize TAMs to an anti-tumor phenotype to facilitate reduction in primary and metastatic tumor burden. In addition, we have found that some types of therapy such as poly(ADP-ribose) polymerase (PARP) inhibition (PARPi) can drive development of highly suppressive TAMs, restricting anti-tumor T cell function and survival. Murine models demonstrate that in the absence of TAMs, PARPi induce a robust recruitment of cytotoxic T cells and durable antitumor responses. Therefore, targeting TAMs is a promising strategy for improving PARPi treatment efficacy. However, while there is an urgent need to target TAMs during tumorigenesis and cancer therapy, to date, failure to fully characterize TAM biology and classify multiple subsets has hindered advancement in therapeutic targeting. Deep analysis of TAMs in solid tumors has revealed the complexity of TAMs and revealed major gaps in our knowledge of the functional and phenotypic characterization of TAM subsets associated with cancer, before and after treatment. Here we will discuss the complexity of TAMs in solid tumors including characterizing TAM subsets, location, and crosstalk with neighboring cells, as well as novel TAM-modulating strategies and combinations that are likely to enhance current therapies and overcome chemo- and immuno-therapy resistance. Citation Format: Jennifer L Guerriero. The complexities of tumor associated macrophages and the key to effective targeting for anti-cancer therapy [abstract]. In: Proceedings of the AACR Special Conference: Tumor Immunology and Immunotherapy; 2022 Oct 21-24; Boston, MA. Philadelphia (PA): AACR; Cancer Immunol Res 2022;10(12 Suppl) nr IA16.

At the interface of tumor-associated macrophages and fibroblasts: immune-suppressive networks and emerging exploitable targets

Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy

Decoding the spatiotemporal heterogeneity of tumor-associated macrophages

Tumor‐associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire

Targeting of TAMs: can we be more clever than cancer cells?

Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives

Tumor-Associated Macrophages as Major Immunosuppressive Cells in the Tumor Microenvironment

CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion

Microenvironmental regulation in tumor progression: Interactions between cancer-associated fibroblasts and immune cells

Targeting Tumor-Associated Macrophages in Anti-Cancer Therapies: Convincing the Traitors to Do the Right Thing

Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution

Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy

Tumor-associated myeloid cells: diversity and therapeutic targeting

Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer

Roles of Tumor-Associated Macrophages in Tumor Environment and Strategies for Targeting Therapy

Abstract SY37-03: Leveraging the complexities of tumor associated macrophages for effective anti-cancer therapy

Role of cancer‐associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer

Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment

Abstract IA16: The complexities of tumor associated macrophages and the key to effective targeting for anti-cancer therapy

Targeting Tumor-Associated Macrophages As an Antitumor Strategy.